Axon Enterprise, Inc. (NASDAQ:AXON) Shares Purchased by Fifth Third Wealth Advisors LLC

Fifth Third Wealth Advisors LLC raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 35.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,082 shares of the biotechnology company’s stock after purchasing an additional 283 shares during the period. Fifth Third Wealth Advisors LLC’s holdings in Axon Enterprise were worth $432,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of AXON. 1832 Asset Management L.P. acquired a new position in Axon Enterprise during the first quarter worth approximately $81,630,000. International Assets Investment Management LLC acquired a new stake in shares of Axon Enterprise in the third quarter worth $871,860,000. Swedbank AB acquired a new stake in shares of Axon Enterprise in the first quarter worth $39,923,000. Mizuho Securities USA LLC increased its position in shares of Axon Enterprise by 1,077.9% in the third quarter. Mizuho Securities USA LLC now owns 64,418 shares of the biotechnology company’s stock worth $25,741,000 after acquiring an additional 58,949 shares in the last quarter. Finally, Vaughan Nelson Investment Management L.P. increased its position in shares of Axon Enterprise by 53.2% in the second quarter. Vaughan Nelson Investment Management L.P. now owns 157,094 shares of the biotechnology company’s stock worth $46,223,000 after acquiring an additional 54,526 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $609.82 on Thursday. The firm has a fifty day moving average of $453.48 and a two-hundred day moving average of $363.68. The stock has a market capitalization of $46.50 billion, a price-to-earnings ratio of 157.58, a PEG ratio of 15.05 and a beta of 0.94. Axon Enterprise, Inc. has a 52 week low of $224.28 and a 52 week high of $624.84. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Analyst Ratings Changes

Several research firms have recently issued reports on AXON. JMP Securities increased their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Robert W. Baird raised their price target on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Craig Hallum raised their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Finally, Barclays increased their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus price target of $427.83.

Insider Activity

In related news, CFO Brittany Bagley sold 4,338 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total value of $1,643,885.10. Following the completion of the transaction, the chief financial officer now directly owns 98,825 shares of the company’s stock, valued at approximately $37,449,733.75. This represents a 4.20 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the transaction, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. The trade was a 2.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 410,556 shares of company stock valued at $161,192,754 in the last quarter. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.